Trial Filter

BETA

An intelligent search tool for clinical trials

Sign In
Back|NCT06026332Recruiting
Official Title

ADSTILADRIN Early Utilization and Outcomes in the Real World Setting

Sponsor
Ferring Pharmaceuticals
Enrollment
400
Timeline
Sep 2023 → Dec 2027
About This Study

Multi-center, prospective non-interventional study to collect data on the early use of Adstiladrin in the US and Israel. Data will be collected from patients and prescribing physicians in a real-world setting

Eligibility Criteria

Inclusion Criteria

  • 1Prescribed and scheduled treatment with ADSTILADRIN per physician discretion or received the first instillation of ADSTILADRIN per physician discretion after 5 September 2023 but prior to site activation
  • 2Signed and dated ICF.
  • 3Age 18 years or older at day ICF is signed.

Exclusion Criteria

  • 1Currently enrolled in a clinical trial.
  • 2Participants who have previously been treated with ADSTILADRIN in the context of a clinical trial
  • 3Participant is pregnant or breastfeeding.

Locations

31 sites participating in this study

Emory University

Atlanta, Georgia 30308

Recruiting

Banner Health MD Anderson Cancer Center

Gilbert, Arizona 85234

Recruiting

Mayo Clinic Arizona

Phoenix, Arizona 85054

Recruiting
Data sourced from ClinicalTrials.govView on ClinicalTrials.gov →